Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis
Open Access
- 12 December 2002
- journal article
- research article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 9 (12), 1321-1333
- https://doi.org/10.1038/sj.cdd.4401107
Abstract
The HT29 adenocarcinoma is a common model of epithelial cell differentiation and colorectal cancer and its death is an oft-analyzed response to TNF family receptor signaling. The death event itself remains poorly characterized and here we have examined the involvement of caspases using pan-caspase inhibitors. zVAD-fmk did not block death of HT29 cells in response to activation of the Fas, TRAIL, TNF, TWEAK and LTβ receptors. The secondary induction of TNF or the other known bona fide death inducing ligands did not account for death following LTβ receptor activation indicating that TNF family receptors can trigger a caspase-independent death pathway regardless of the presence of canonical death domains in the receptor. To provide a frame of reference, the phenotype of HT29 death was compared to four other TNF family receptor triggered death events; Fas induced Jurkat cell apoptosis, TNF/zVAD induced L929 fibroblast necrosis, TNF induced death of WEHI 164 fibroblastoid cells and TNF/zVAD induced U937 death. The death of HT29 and U937 cells under these conditions is an intermediate form with both necrotic and apoptotic features. The efficient coupling of TNF receptors to a caspase-independent death event in an epithelial cell suggests an alternative approach to cancer therapy.Keywords
This publication has 70 references indexed in Scilit:
- Wengen, a Member of the Drosophila Tumor Necrosis Factor Receptor Superfamily, Is Required for Eiger SignalingJournal of Biological Chemistry, 2002
- Resistance to the Cytotoxic Effects of Tumor Necrosis Factor α Can Be Overcome by Inhibition of a FADD/Caspase-dependent Signaling PathwayPublished by Elsevier ,1999
- TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMSAnnual Review of Immunology, 1999
- The Cytoplasmic Domain of the Lymphotoxin-β Receptor Mediates Cell Death in HeLa CellsJournal of Biological Chemistry, 1999
- Supraoptimal Peptide–Major Histocompatibility Complex Causes a Decrease in Bcl-2 Levels and Allows Tumor Necrosis Factor α Receptor II–mediated Apoptosis of Cytotoxic T LymphocytesThe Journal of Experimental Medicine, 1998
- Interferon-γ-Induced Differentiation and Apoptosis of HT29 Cells: Dissociation of (Glucosyl)ceramide SignalingBiochemical and Biophysical Research Communications, 1998
- TUMOUR NECROSIS FACTOR-INDUCED NECROSIS VERSUS ANTI-Fas-INDUCED APOPTOSIS IN L929 CELLSCytokine, 1997
- Target Cell Lysis by CTL Granule Exocytosis Is Independent of ICE/Ced-3 Family ProteasesImmunity, 1997
- Preparation and Characterization of Soluble Recombinant Heterotrimeric Complexes of Human Lymphotoxins andPublished by Elsevier ,1996
- Aspartate-Based Inhibitor of Interleukin-1β-Converting Enzyme Prevents Antitumor Agent-Induced Apoptosis in Human Myeloid Leukemia U937 CellsBiochemical and Biophysical Research Communications, 1995